Net Loss of Astrazeneca Pharma India reported to Rs 18.58 crore in the quarter ended March 2013 as against net loss of Rs 33.01 crore during the previous quarter ended March 2012. Sales rose 3.45% to Rs 94.85 crore in the quarter ended March 2013 as against Rs 91.69 crore during the previous quarter ended March 2012.
For the Audited full year,net loss reported to Rs 89.53 crore in the year ended March 2013 as against net profit of Rs 19.77 crore during the previous year ended March 2012. Sales declined 26.55% to Rs 390.25 crore in the year ended March 2013 as against Rs 531.28 crore during the previous year ended March 2012.
ParticularsQuarter EndedYear EndedMar. 2013Mar. 2012% Var.Mar. 2013Mar. 2012% Var.Sales94.8591.69 3 390.25531.28 -27 OPM %-14.52-53.62 73 -17.545.70 -408 PBDT-13.10-47.15 72 -57.9936.60 PL PBT-18.58-48.96 62 -70.2729.26 PL NP-18.58-33.01 44 -89.5319.77 PL
Powered by Capital Market - Live News
